Skip to main content

$0.022 (0.00%)

High

$0.02

Low

$0.02

Trades

56

Turnover

$22,520

Volume

1,033,118
30 June 2023 at 3:59pm
Register to track AT1 and receive email alerts.

Atomo receives TGA approval for AtomoRapid HIV (1&2) test

StockBot

416,823 posts

AT1 released this announcement to the ASX on 10 November 2020, 8:21. The announcement is marked as price sensitive, and is 2 page(s) in length and 355.89kb in size.

You can view all announcements from AT1 and see how they appear on a price chart on the announcements page.

At the date of this announcement, AT1 was 0.723% short sold according to ASIC data. It was ranked the 246th most shorted stock on the ASX. It remains ranked 384th as of the latest reported data (07 August 2023).

Other Recent Announcements from AT1
Ceasing to be a substantial holder 23 June 2023, 16:26
Exclusive Agreement for HIV Testing Signed with Newfoundland 14 June 2023, 9:54
Change in substantial holding 6 June 2023, 18:02
Atomo receives TGA approval for AtomoRapid HIV (1&2) test 10 November 2020, 8:21
Results of the AGM 4 November 2020, 16:23
Managing Director's AGM Presentation 4 November 2020, 9:30
Chairman's AGM Address 4 November 2020, 9:28
You must login or register to post a comment.

You must be logged in to post a reply.

Register to track AT1 and receive email alerts.